Placental Insufficiency Latest Advances

Attenuated estrogen signaling disrupts placentation and drives trophoblast defects in Down syndrome.

Journal: bioRxiv : the preprint server for biology

Published: June 22, 2026

A perinatal approach for unravelling mitochondrial function in preeclampsia and fetal growth restriction: a role for mitochondrial targeted therapies.

Journal: American journal of physiology. Heart and circulatory physiology

Published: June 01, 2026

Maternal Serum Homocysteine as a Severity-Linked Biomarker Across the Spectrum of Hypertensive Disorders of Pregnancy: A Prospective Observational Study.

Journal: Cureus

Published: May 21, 2026

Placental pathology in pregnancies complicated by hypertensive disorders of pregnancy and small for gestational age neonates: prevalence and severity of maternal vascular malperfusion in a prospectively collected cohort.

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Published: May 19, 2026

Late-gestation mineralocorticoid receptor antagonism lowers maternal blood pressure and attenuates placental insufficiency induced by leptin in pregnant mice.

Journal: American journal of physiology. Heart and circulatory physiology

Published: May 14, 2026

Lactotransferrin reduction as a target mechanism of postnatal intestinal vulnerability in murine preeclampsia models.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: May 06, 2026

Correction of hypoxemia and hypoglycemia restores muscle mitochondrial respiration and remodels mitochondrial proteome in growth-restricted sheep fetuses.

Journal: American journal of physiology. Endocrinology and metabolism

Published: April 30, 2026

Beyond preeclampsia: low dose aspirin as a preventative strategy for spontaneous preterm birth.

Journal: Seminars in perinatology

Published: April 29, 2026

Bioethical Considerations of Diagnostic Placental Growth Factor Testing in Canada.

Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC

Published: April 13, 2026

The Role of Fetal Renal Artery Doppler in Predicting Intrauterine Growth Restriction: A Case-Control Study.

Journal: Cureus

Published: April 07, 2026

The Contribution of Ultrasound and Doppler Studies on Impaired Intrauterine Conditions and the Development of Future Disease.

Journal: Medicina (Kaunas, Lithuania)

Published: March 30, 2026

Present status of sFLT1 and PlGF as diagnostic and therapeutic targets for preeclampsia.

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Published: March 25, 2026

Placental Insufficiency Latest Advances

Find the Latest Research About Placental Insufficiency

Attenuated estrogen signaling disrupts placentation and drives trophoblast defects in Down syndrome.

Attenuated estrogen signaling disrupts placentation and drives trophoblast defects in Down syndrome.

A perinatal approach for unravelling mitochondrial function in preeclampsia and fetal growth restriction: a role for mitochondrial targeted therapies.

A perinatal approach for unravelling mitochondrial function in preeclampsia and fetal growth restriction: a role for mitochondrial targeted therapies.

Maternal Serum Homocysteine as a Severity-Linked Biomarker Across the Spectrum of Hypertensive Disorders of Pregnancy: A Prospective Observational Study.

Maternal Serum Homocysteine as a Severity-Linked Biomarker Across the Spectrum of Hypertensive Disorders of Pregnancy: A Prospective Observational Study.

Placental pathology in pregnancies complicated by hypertensive disorders of pregnancy and small for gestational age neonates: prevalence and severity of maternal vascular malperfusion in a prospectively collected cohort.

Placental pathology in pregnancies complicated by hypertensive disorders of pregnancy and small for gestational age neonates: prevalence and severity of maternal vascular malperfusion in a prospectively collected cohort.

Late-gestation mineralocorticoid receptor antagonism lowers maternal blood pressure and attenuates placental insufficiency induced by leptin in pregnant mice.

Late-gestation mineralocorticoid receptor antagonism lowers maternal blood pressure and attenuates placental insufficiency induced by leptin in pregnant mice.

Lactotransferrin reduction as a target mechanism of postnatal intestinal vulnerability in murine preeclampsia models.

Lactotransferrin reduction as a target mechanism of postnatal intestinal vulnerability in murine preeclampsia models.

Correction of hypoxemia and hypoglycemia restores muscle mitochondrial respiration and remodels mitochondrial proteome in growth-restricted sheep fetuses.

Correction of hypoxemia and hypoglycemia restores muscle mitochondrial respiration and remodels mitochondrial proteome in growth-restricted sheep fetuses.

Beyond preeclampsia: low dose aspirin as a preventative strategy for spontaneous preterm birth.

Beyond preeclampsia: low dose aspirin as a preventative strategy for spontaneous preterm birth.

Bioethical Considerations of Diagnostic Placental Growth Factor Testing in Canada.

Bioethical Considerations of Diagnostic Placental Growth Factor Testing in Canada.

The Role of Fetal Renal Artery Doppler in Predicting Intrauterine Growth Restriction: A Case-Control Study.

The Role of Fetal Renal Artery Doppler in Predicting Intrauterine Growth Restriction: A Case-Control Study.

The Contribution of Ultrasound and Doppler Studies on Impaired Intrauterine Conditions and the Development of Future Disease.

The Contribution of Ultrasound and Doppler Studies on Impaired Intrauterine Conditions and the Development of Future Disease.

Present status of sFLT1 and PlGF as diagnostic and therapeutic targets for preeclampsia.

Present status of sFLT1 and PlGF as diagnostic and therapeutic targets for preeclampsia.